Status:
RECRUITING
The Oslo Acute Reperfusion Stroke Study (OSCAR)
Lead Sponsor:
Oslo University Hospital
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Prospective registry of clinical and radiological data in acute ischemic stroke patients after endovascular treatment.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 18 years or older
- Patients with ischemic stroke and cerebral arterial occlusion treated with endovascular revascularization.
- All stroke severities and vascular distributions are eligible.
- Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines.
- Exclusion criteria:
- • Patient not eligible for the study or not available for follow-up assessments (e.g. non- resident).
Exclusion
Key Trial Info
Start Date :
January 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06220981
Start Date
January 10 2017
End Date
December 31 2025
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway